CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 272 | -90.9% | 0.00% | – |
| Q2 2021 | $8,000 | +166.7% | 3,000 | +200.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 1,000 | +371.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 212 | +0.5% | 0.00% | – |
| Q2 2020 | $1,000 | – | 211 | +0.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 210 | -17.0% | 0.00% | – |
| Q3 2018 | $2,000 | – | 253 | +1586.7% | 0.00% | – |
| Q2 2018 | $0 | – | 15 | +400.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 3 | -96.4% | 0.00% | – |
| Q4 2017 | $1,000 | -90.9% | 84 | -88.3% | 0.00% | – |
| Q3 2017 | $11,000 | – | 720 | +2566.7% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 27 | -76.9% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 117 | -25.9% | 0.00% | – |
| Q4 2016 | $2,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
| Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
| BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
| Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
| COWEN INC. | 588,706 | $5,051,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
| EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
| Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
| Hikari Power Ltd | 32,090 | $275,000 | 0.03% |